ConductScience.org, home

Paper407012

Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility.

Cumber AJ and 1 other. Chem Biol Interact, 1977. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility. Papers, record 407012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/407012

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility.
PubMed
Journal
Chem Biol Interact
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
2
iCite
Revised in PubMed
2019-08-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cumber AJA J
2Ross WCW C

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AltretamineMajor topic
TriazinesMajor topic
Animals
Humans
Lung Neoplasms
Mice
Neoplasm Transplantation
Neoplasms, Experimental
Plasmacytoma
Solubility
Structure-Activity Relationship
Transplantation, Heterologous

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
7656502Clinical pharmacokinetics of altretamine.Clin Pharmacokinet1995https://conductscience.org/library/papers/7656502PubMed
7272193British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts.Br J Cancer1981https://conductscience.org/library/papers/7272193PubMed
6808457Hexamethylmelamine and hexamethylmelamine hydrochloride.Pharm Weekbl Sci1982https://conductscience.org/library/papers/6808457PubMed
6807560The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouse.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6807560PubMed
6401427Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.Br J Cancer1983https://conductscience.org/library/papers/6401427PubMed
3098444Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenografts.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3098444PubMed
3091280
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.
Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3091280PubMed
3087399Low central nervous system penetration of N2,N4,N6,-trihydroxymethyl-N2,N4,N6,-trimethylmelamine (Trimelamol): a cytotoxic s-triazine with reduced neurotoxicity.Br J Cancer1986https://conductscience.org/library/papers/3087399PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/407012

GET https://conductscience.org/api/papers/v1/407012/authors